<DOC>
	<DOCNO>NCT01553136</DOCNO>
	<brief_summary>The purpose study determine whether varenicline effective treatment alcohol dependence smoker .</brief_summary>
	<brief_title>Varenicline Treatment Alcohol Dependence Smokers</brief_title>
	<detailed_description>Building upon knowledge role nicotinic acetylcholine receptor alcohol drink smoking , varenicline , smoke cessation treatment target receptor , test potential treatment alcohol dependent smoker seek alcohol treatment .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>18 70 year age seek treatment alcohol drinking ; meet DSMIV TR Criteria Alcohol Dependence report smoke 100 cigarette lifetime currently smoke least twice weekly average past 90 day urinary cotinine level &gt; 30ng/mL semiquantitative urinalysis equivalent plasma cotinine level ( &gt; 6 ng/mL ) ; report heavy drink least 2 day average per week ( i.e. , ≥ 4 drink occasion woman ≥ 5 drink men ) past 90 day 7 consecutive day abstinence intake . exhibit current , clinically significant physical disease abnormality base medical history , physical examination , routine laboratory evaluation include : unexplained elevation liver enzymes ( i.e. , transaminase , bilirubin ) clinically significant , unstable cardiovascular disease/uncontrolled hypertension hepatic renal impairment severe obstructive pulmonary disease diabetes mellitus require insulin certain oral medication ( i.e. , sulfonylurea ) A1C hemoglobin test score &gt; 7 participant prescribed medication baseline systolic blood pressure high 150 mm Hg diastolic blood pressure high 95 mm Hg history cancer ( except treat basal cell squamous cell carcinoma skin ) history serious hypersensitivity reaction skin reaction varenicline ; exhibit serious psychiatric illness ( i.e. , schizophrenia , bipolar disorder , severe major depression , panic disorder , borderline personality disorder , organic mood mental disorder history psychological examination report current suicidal ideation ( past 6 month ) lifetime hx suicidal behavior assess Columbia Suicide Severity Rating Scale 60 ; risk aggression use cutoff 15 Overt Aggression Scale Modified Aggression Scale 6 OASM Irritability Subscale 61. use psychotropic drug past month , except individual stable dose Selective Serotonin Reuptake Inhibitor least two month report occasional use prescription sleep aid willing discontinue ; current DSMIV diagnosis drug dependence nicotine alcohol risk alcohol withdrawal syndrome evidence : history seizure , delirium , hallucination alcohol withdrawal Clinical Institute Withdrawal Assessment scale 62 score &gt; 8 , report drink avoid withdrawal symptom require medical treatment alcohol withdrawal within past 6 month use another investigational drug within 30 day use medication treat alcohol ( e.g. , naltrexone , topiramate , acamprosate , disulfiram ) nicotine use ( e.g. , clonidine , varenicline , bupropion , nicotine replacement ) past 3 month intend use medication ; prior use nicotine replacement situation smoke permit ( e.g. , plane ) without intention quit smoking exclusionary ; intend donate blood blood product treatment phase study Body Mass Index ( calculate weight kilogram divide square height meter ) less 15 great 39.99 weight less 45 kg ; female childbearing potential pregnant , nursing , practice effective contraception ( oral , injectable , implantable contraceptive , intrauterine device , barrier method spermicide ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>alcohol-related disorder</keyword>
	<keyword>Cholinergic Drugs</keyword>
	<keyword>varenicline</keyword>
	<keyword>Chantix</keyword>
</DOC>